Literature DB >> 18220894

Stem cell migration: a quintessential stepping stone to successful therapy.

Corinna Weidt1, Bernd Niggemann, Benjamin Kasenda, Theodore L Drell, Kurt S Zänker, Thomas Dittmar.   

Abstract

Migration is an innate and fundamental cellular function that enables hematopoietic stem cells (HSCs) and endothelial progenitors (EPCs) to leave the bone marrow, relocate to distant tissue, and to return to the bone marrow. An increasing number of studies demonstrate the widening scope of the therapeutic potential of both HSCs and endothelial cells. Therapeutic success however not only relies upon their ability to repair damaged tissue, but is also fundamentally dependent on the migration to these areas. Extensive in vivo and in vitro research efforts have shown that the most significant effects seen on HSC migration are initiated by the chemokine SDF-1alpha. In this review we will elucidate the many cellular and systemic factors of HSC and EPC cell migration and their modi operandi.

Mesh:

Substances:

Year:  2007        PMID: 18220894     DOI: 10.2174/157488807779317008

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  19 in total

Review 1.  Therapeutic window, a critical developmental stage for stem cell therapies.

Authors:  Shengwen Calvin Li; Yuan-Ping Han; Brent A Dethlefs; William G Loudon
Journal:  Curr Stem Cell Res Ther       Date:  2010-12       Impact factor: 3.828

Review 2.  Functional diversity of SDF-1 splicing variants.

Authors:  Miroslaw Janowski
Journal:  Cell Adh Migr       Date:  2009-07-23       Impact factor: 3.405

Review 3.  Training stem cells for treatment of malignant brain tumors.

Authors:  Shengwen Calvin Li; Mustafa H Kabeer; Long T Vu; Vic Keschrumrus; Hong Zhen Yin; Brent A Dethlefs; Jiang F Zhong; John H Weiss; William G Loudon
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

4.  Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2.1 channel and FAK activation.

Authors:  Xinyang Hu; Ling Wei; Tammi M Taylor; Jianfeng Wei; Xin Zhou; Jian-An Wang; Shan Ping Yu
Journal:  Am J Physiol Cell Physiol       Date:  2011-05-11       Impact factor: 4.249

5.  Microenvironmental regulation of chemokine (C-X-C-motif) receptor 4 in ovarian carcinoma.

Authors:  Maria V Barbolina; Mijung Kim; Yueying Liu; Jaclyn Shepard; Abdelhak Belmadani; Richard J Miller; Lonnie D Shea; M Sharon Stack
Journal:  Mol Cancer Res       Date:  2010-05-11       Impact factor: 5.852

Review 6.  The ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes.

Authors:  Leah A Marquez-Curtis; A Robert Turner; Santhi Sridharan; Mariusz Z Ratajczak; Anna Janowska-Wieczorek
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

7.  Hyaluronan expressed by the hematopoietic microenvironment is required for bone marrow hematopoiesis.

Authors:  Valentina Goncharova; Naira Serobyan; Shinji Iizuka; Ingrid Schraufstatter; Audrey de Ridder; Tatiana Povaliy; Valentina Wacker; Naoki Itano; Koji Kimata; Irina A Orlovskaja; Yu Yamaguchi; Sophia Khaldoyanidi
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

Review 8.  Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner.

Authors:  Thomas Dittmar; Christoph Heyder; Eva Gloria-Maercker; Wolfgang Hatzmann; Kurt S Zänker
Journal:  Clin Exp Metastasis       Date:  2007-09-08       Impact factor: 5.150

9.  Therapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis.

Authors:  Anandharajan Rathinasabapathy; Erin Bruce; Andrew Espejo; Alana Horowitz; Dhivya R Sudhan; Anand Nair; Dominic Guzzo; Joseph Francis; Mohan K Raizada; Vinayak Shenoy; Michael J Katovich
Journal:  Br J Pharmacol       Date:  2016-08-26       Impact factor: 8.739

10.  Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature.

Authors:  George J Klarmann; Elaine M Hurt; Lesley A Mathews; Xiaohu Zhang; Maria A Duhagon; Tashan Mistree; Suneetha B Thomas; William L Farrar
Journal:  Clin Exp Metastasis       Date:  2009-02-17       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.